Regencell Bioscience (RGC) has had the highest return since July 1, 2024 by a mid-cap US stock, returning 20,300.5%.
| ASSET | % RETURN |
|---|---|
Regencell Bioscience (RGC) | 20,300.49% |
QMMM Holdings Limited Ordinary Shares (QMMM) | 3,880% |
Quantum Computing (QUBT) | 3,606.63% |
Ondas (ONDS) | 1,511.89% |
Uniqure (QURE) | 1,286.37% |
CommScope (COMM) | 1,125.41% |
Eos Energy Enterprises (EOSE) | 908.76% |
Cidara Therapeutics (CDTX) | 845.23% |
Centrus Energy (LEU) | 736.88% |
Planet Labs PBC (PL) | 690.32% |
Verona Pharma PLC ADR (VRNA) | 645.02% |
Abivax SA American Depositary Shares (ABVX) | 591.26% |
TMC the metals (TMC) | 548.54% |
Dave (DAVE) | 536.86% |
Lumen Technologies (LUMN) | 526.67% |
Applied Digital (APLD) | 471.26% |
Anbio Biotechnology Class A Ordinary Shares (NNNN) | 467.49% |
Innodata (INOD) | 458.93% |
Solaris Energy Infrastructure (SEI) | 439.83% |
Sezzle (SEZL) | 434.92% |
Hesai Group American Depositary Share, each ADS represents one Class B ordinary share (HSAI) | 423.75% |
Perpetua Resources (PPTA) | 399.81% |
SSR Mining (SSRM) | 393.19% |
Kingsoft Cloud Holdings (KC) | 391.44% |
BigBearai (BBAI) | 384.56% |
Mid-cap stocks are treated as having a market cap between $2B and $10B.
